Related Experiment Video
Updated: Jun 17, 2026
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks
Eric I Benchimol1, Catharine M Walsh, Simon C Ling
1Division of Gastroenterology, Hepatology and Nutrition at Hospital for Sick Children,Toronto, Ont.
Insights
Early detection of neonatal cholestasis is crucial. Testing infants with jaundice at two weeks for direct bilirubin levels can lead to timely diagnosis and improved outcomes.
Area of Science:
- Neonatology
- Pediatric Gastroenterology
- Bilirubin Metabolism
Background:
- Neonatal cholestasis, a serious condition, requires prompt identification.
- Delayed diagnosis can lead to irreversible liver damage and poor long-term outcomes.
Purpose of the Study:
- To review best practices for early recognition and treatment of neonatal cholestasis.
- To improve long-term outcomes for infants affected by this condition.
Main Methods:
- Comprehensive literature search of electronic databases for studies on neonatal cholestasis.
- Inclusion of review articles and meta-analyses with Level II and III evidence.
- Analysis of studies emphasizing early diagnosis and intervention for cholestatic jaundice.
Main Results:
- Recommends testing infants with jaundice at 2 weeks for direct bilirubin levels.
- Highlights the utility of a diagnostic algorithm for rapid, specific diagnosis.
- Emphasizes that timely intervention improves outcomes for treatable conditions.
Conclusions:
- Universal screening for neonatal cholestasis may enhance early case identification and outcomes.
- Further research is needed to validate universal screening in North America.
Objective:
To review best practices for early recognition and treatment of conditions resulting in neonatal cholestasis, in order to improve long-term outcomes for affected infants.
Quality Of Evidence:
Studies, review articles, and meta-analyses pertaining to neonatal-onset cholestasis were sought via electronic databases. Reference lists of studies and review articles supplemented the electronic search. Studies were included if they examined the importance of early diagnosis and intervention for cholestatic jaundice of any cause, and mainly comprised Level II and Level III evidence.
Main Message:
Review of the relevant literature supports the recommendation that infants with jaundice at 2 weeks of age should be tested for cholestasis by quantifying the direct reacting bilirubin levels in their blood. Subsequent rapid investigation using a diagnostic algorithm enables early diagnosis of the specific cause and facilitates timely intervention for conditions whose outcomes are improved by early treatment.
Conclusion:
Universal screening for neonatal cholestasis might help with early identification of cases and improve outcomes, although further study is required in the North American setting.
Related Concept Videos
01:25Jaundice
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests